The Standard Management of HPV Infection

NCT03577925 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 800

Last updated 2018-07-05

No results posted yet for this study

Summary

High-risk human papillomavirus (HR-HPV) infection is a necessary condition in the occurence and development of cervical squamous intraepithelial lesion (SIL) and cervical cancer. There are cases that high-grade SIL (HSIL) and stage IA1 cervical squamous cancer remain or reoccur, or even become more severe after conization. The infection situation of HR-HPV, which plays an important role in the prognosis of cervical lesion, should be consulted in the management and follw-up after conization. It is worthwhile making further study in the specific practical significance of the HR-HPV in the prognosis of cervical lesion, as well as the high-risk factors that influence the prognosis of HR-HPV.

Conditions

  • the High-Risk HPV Infection

Interventions

DIAGNOSTIC_TEST

HPV genotype test

HPV genotype test is a diagnostic test by smearing the cervix to find out whether a patient is hpv infected, and if infected, the test can descover the concrete hpv genotype.

Sponsors & Collaborators

  • Capital Medical University

    lead OTHER

Principal Investigators

  • Yu mei Wu, Doctor · Beijing Obstetrics and Gynecology Hospital

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-10-01
Primary Completion
2018-10-01
Completion
2019-06-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03577925 on ClinicalTrials.gov